Literature DB >> 12820452

Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.

Maurizio Soresi1, Carmela Magliarisi, Pietro Campagna, Gaetano Leto, Giulio Bonfissuto, Anna Riili, Antonio Carroccio, Roberta Sesti, Silvio Tripi, Giuseppe Montalto.   

Abstract

With the widespread use of ultrasonography (US) and computerized tomography (CT), the usefulness of alpha-fetoprotein assay in the diagnosis of hepatocellular carcinoma (HCC) has decreased. The aim of our study was to evaluate the best cut-off value for serum alpha-fetoprotein to discriminate between liver cirrhosis (LC) and HCC and the factors influencing levels in a Sicilian population. Three hundred and seventy-two patients with LC and 197 with HCC-associated LC were studied. The etiology was: HCV in 288 cases (77.4%) of LC and 147 cases (75%) of HCC; HBV in 31 cases (8.3%) of LC and 15 cases (7.6%) of HCC; HCV/HBV in 21 cases (5.6%) of LC and 6 cases (3.0%) of HCC; non-viral in 32 cases (8.6%) of LC and 29 cases (15%) of HCC. Hepatic function was estimated by the Child-Pugh's score; the TNM classification was used in HCC. The area under the ROC curve was 0.81 +/- 0.02; the best discriminant cut-off value, calculated as the value of the maximized likelihood ratio, was 30 ng/ml. At this level sensitivity (SE) was 65%, specificity (SP) 89%, positive predictive value (PPV) 74% and negative predictive value (NPV) 79%. When the patients were divided at this cut-off point into two groups according to viral or non-viral etiology, PPV was 70% versus 94%, respectively (p < 0.05). In the non-viral diseases PPV reached 100% for AFP serum levels of 100 ng/ml, while in the viral diseases PPV was 100% when AFP was greater than 400 ng/ml. There were no significant differences in SE, SP or NPV between viral and non-viral liver diseases. Child's classes B and C were more frequent in HCC (chi 2 of MH 7.7, p < 0.0001). There was a correlation between AFP serum values and TNM classification (p < 0.02) and on multiple logistic regression AFP levels > 30 ng/ml correlated positively only with the TNM stage (p < 0.0001). In conclusion, the best cut-off value for serum AFP in our study population was 30 ng/ml, but at this level sensitivity was low. This cut-off value was more useful in detecting non-viral HCC, because PPV was significantly higher than in viral HCC; therefore, our data confirm that the usefulness of AFP in the diagnosis of HCC of viral etiology is limited, being more useful in HCC of non-viral etiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820452

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  52 in total

1.  Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients.

Authors:  Peter Richardson; Zhigang Duan; Jennifer Kramer; Jessica A Davila; Gia L Tyson; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-07       Impact factor: 11.382

2.  Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients.

Authors:  Hatem A El-mezayen; Hossam Darwish
Journal:  Tumour Biol       Date:  2014-04-01

3.  Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy.

Authors:  Shun-Jun Fu; Shun-Li Shen; Shao-Qiang Li; Yun-Peng Hua; Wen-Jie Hu; Li-Jian Liang; Bao-Gang Peng
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

4.  Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis.

Authors:  Jie-Feng Cui; Yin-Kun Liu; Hai-Jun Zhou; Xiao-Nan Kang; Cheng Huang; Yi-Feng He; Zhao-You Tang; Toshimasa Uemura
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

5.  Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate.

Authors:  Mohd Farhan; Asim Rizvi; Imrana Naseem; S M Hadi; Aamir Ahmad
Journal:  Tumour Biol       Date:  2015-06-12

6.  Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma.

Authors:  Dingxin Wang; Brian Jin; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Mary F Mulcahy; Laura M Kulik; Frank H Miller; Riad Salem; Debiao Li; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

7.  Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?

Authors:  Chung-Bao Hsieh; Teng-Wei Chen; Chi-Ming Chu; Heng-Cheng Chu; Cheng-Ping Yu; Kuo-Piao Chung
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

8.  Elevated alpha fetoprotein, no hepatocellular carcinoma.

Authors:  Mallikarjun Patil; Keyur A Sheth; Channagiri K Adarsh
Journal:  J Clin Exp Hepatol       Date:  2013-03-05

9.  A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma.

Authors:  Nabil Mohie Abdel-Hamid; M M Abouzied; M H Nazmy; M A Fawzy; A S Gerges
Journal:  Tumour Biol       Date:  2015-09-19

Review 10.  Serum tumor markers for detection of hepatocellular carcinoma.

Authors:  Lin Zhou; Jia Liu; Feng Luo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.